|1.||Neu, Ursula: 1 article (10/2015)|
|2.||Stehle, Thilo: 1 article (10/2015)|
|3.||Liaci, A Manuel: 1 article (10/2015)|
|4.||Garcea, Robert L: 1 article (10/2015)|
|5.||O'Hara, Samantha D: 1 article (10/2015)|
|6.||Buch, Michael H C: 1 article (10/2015)|
|7.||Doerner, David Z: 1 article (07/2013)|
|8.||Mayfield, Stephen: 1 article (07/2013)|
|9.||Gregory, James A: 1 article (07/2013)|
|10.||Topol, Aaron B: 1 article (07/2013)|
|1.||Human Influenza (Influenza)
07/01/2013 - "The noncatalytic CtxB domain of the cholera holotoxin assembles into a pentameric structure and acts as a mucosal adjuvant by binding GM1 ganglioside receptors on gut epithelial cells. "
09/19/2008 - "The non-toxic B subunit of cholera toxin (CTB) is an active substance in the oral cholera vaccine, and has been shown to bind ganglioside receptors and activate mucosal cells. "
05/03/2002 - "Uncoupling of the cholera toxin-G(M1) ganglioside receptor complex from endocytosis, retrograde Golgi trafficking, and downstream signal transduction by depletion of membrane cholesterol."
01/01/2008 - "Cholera toxin (CT) is an archetypal bacterial toxin that binds with a high affinity to the receptor ganglioside GM1 on the intestinal epithelial surface and that causes the severe watery diarrhea characteristic of the disease cholera. "
10/01/2015 - "Infection is initiated by attachment of the virus to ganglioside receptors at the cell surface. "
06/01/2009 - "The murine polyomavirus (Py) binds to the lipid receptor ganglioside GD1a and traffics to the endoplasmic reticulum (ER) where it enters the cytosol and then the nucleus to initiate infection. "
08/08/1984 - "Changes in culture conditions that were shown to decrease the receptor ganglioside content of the cells resulted in a corresponding decrease in susceptibility to infection. "